Sales of contact lenses increased by 22 percent to $51.2 million in the second quarter for Valeant Pharmaceuticals, the parent company of Bausch & Lomb. They were up by 19 percent in the first six months of this year, driven by BioTrue, which has been launched also in China. Valeant's ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.